Senate Bill 696
2023-2024 Regular Session
An Act providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; establishing the Pharmaceutical Transparency Review Fund; and imposing a penalty.
Co-Sponsorship Memo
Prime Sponsor
Senator Sharif Street
D Senate District 3
Co-Sponsors
Sen. Daniel Laughlin
R Senate District 49
Sen. Wayne Fontana
D Senate District 42
Sen. Vincent Hughes
D Senate District 7
Sen. Timothy Kearney
D Senate District 26
Sen. Amanda Cappelletti
D Senate District 17
Sen. Jay Costa
D Senate District 43
Sen. Jimmy Dillon
D Senate District 5
Sen. Maria Collett
D Senate District 12
Bill Status & History
Last Action: Referred to Banking & Insurance, May 15, 2023
Senate
S
H
| 0759 | Referred to Banking & Insurance, May 15, 2023 |
Printers Numbers
Votes
There are no votes available.
Committee Meetings
There are no committee meetings available.
Statute References
There are no statute references for this bill.
Senate Bill 696
2023-2024 Regular Session
Sponsors
STREET, LAUGHLIN, FONTANA, HUGHES, KEARNEY, CAPPELLETTI, COSTA, DILLON, COLLETT
Short Title
An Act providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; establishing the Pharmaceutical Transparency Review Fund; and imposing a penalty.
Memo Subject
Pharmaceutical Transparency
Actions
| 0759 | Referred to BANKING AND INSURANCE, May 15, 2023 |
Generated 07/08/2024 04:13 PM